UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 388

Sortiert nach

Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

Clinical infectious diseases, 2016-02, Vol.62 (3), p.362-368

2016

Link zum Volltext

Verfügbarkeit prüfen

Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment

The Journal of infectious diseases, 2017-08, Vol.216 (suppl_3), p.S445-S451

2017

Link zum Volltext

Verfügbarkeit prüfen

Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective

Clinical infectious diseases, 2022-08, Vol.75 (3), p.534-544

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

Clinical infectious diseases, 2009-05, Vol.48 (10), p.1441-1458

2009

Link zum Volltext

Verfügbarkeit prüfen

Fungal cell membrane—promising drug target for antifungal therapy

Journal of applied microbiology, 2016-12, Vol.121 (6), p.1498-1510

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical Impact of Polymerase Chain Reaction–Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study

Clinical infectious diseases, 2023-07, Vol.77 (1), p.38-45

2023

Link zum Volltext

Verfügbarkeit prüfen

Changing epidemiology of candidaemia in Australia

Journal of antimicrobial chemotherapy, 2017-04, Vol.72 (4), p.1103-1108

2017

Link zum Volltext

Verfügbarkeit prüfen

PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis

Journal of antimicrobial chemotherapy, 2016-12, Vol.71 (12), p.3528-3535

2016

Link zum Volltext

Verfügbarkeit prüfen

Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis

Clinical infectious diseases, 2017-06, Vol.64 (11), p.1619-1621

2017

Link zum Volltext

Verfügbarkeit prüfen

Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania

Journal of antimicrobial chemotherapy, 2014-11, Vol.69 (11), p.2979-2983

2014

Link zum Volltext

Verfügbarkeit prüfen

Exploring synergy between azole antifungal drugs and statins for Candida auris

Journal of antimicrobial chemotherapy, 2023-12, Vol.78 (12), p.2824-2829

2023

Link zum Volltext

Verfügbarkeit prüfen

Ibrexafungerp: A novel oral glucan synthase inhibitor

Medical mycology (Oxford), 2020-07, Vol.58 (5), p.579-592

2020

Link zum Volltext

Verfügbarkeit prüfen

New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?

Journal of antimicrobial chemotherapy, 2016-08, Vol.71 (8), p.2075-2078

2016

Link zum Volltext

Verfügbarkeit prüfen

Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study

The Journal of infectious diseases, 2020-03, Vol.221 (Suppl 2), p.S139-S147

2020

Link zum Volltext

Verfügbarkeit prüfen

The effect of antifungal resistance development on the virulence of Candida species

FEMS yeast research, 2022-04, Vol.22 (1)

2022

Link zum Volltext

Verfügbarkeit prüfen

New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease

Brain (London, England : 1878), 2024-05, Vol.147 (5), p.1710-1725

2024

Link zum Volltext

Verfügbarkeit prüfen

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany

Journal of antimicrobial chemotherapy, 2015-05, Vol.70 (5), p.1522-1526

2015

Link zum Volltext

Verfügbarkeit prüfen

Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus

Journal of antimicrobial chemotherapy, 2017-12, Vol.72 (12), p.3325-3333

2017

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance

Medical mycology (Oxford), 2024-03, Vol.62 (4)

2024

Link zum Volltext

Verfügbarkeit prüfen

Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa

Journal of antimicrobial chemotherapy, 2016-07, Vol.71 (7), p.1994-2004

2016

Link zum Volltext

Verfügbarkeit prüfen

Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India

Journal of antimicrobial chemotherapy, 2014-02, Vol.69 (2), p.555-557

2014

Link zum Volltext

Verfügbarkeit prüfen

Are Echinocandins Superior in Efficacy to Azoles?

Clinical infectious diseases, 2020-04, Vol.70 (9), p.2020-2021

Spellberg, Brad

2020

Link zum Volltext

Verfügbarkeit prüfen

Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands

Journal of antimicrobial chemotherapy, 2015-01, Vol.70 (1), p.178-181

2015

Link zum Volltext

Verfügbarkeit prüfen

Spectrophotometric azole and amphotericin B MIC readings against Aspergillus fumigatus sensu lato using the EUCAST 9.3.2 methodology. Are ≥90 and ≥95% fungal growth inhibition endpoints equally suitable?

Medical mycology (Oxford), 2021-12, Vol.60 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim

Journal of antimicrobial chemotherapy, 2022-05, Vol.77 (6), p.1645-1654

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 388

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieInternational Journal Of Radiation Oncology, Biology, Physics

Zeitschrift / SerieMycoses

KollektionOxford Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(368)
Mit Volltextzugriff
(371)

Publikationsform

Artikel
(388)

Sprache

Englisch
(388)
Japanisch
(64)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(356)
Science & Technology
(356)
Infectious Diseases
(254)
Antifungal Agents - Pharmacology
(235)
Microbiology
(233)
Humans
(232)
Azoles - Pharmacology
(200)
Biological And Medical Sciences
(165)
Azoles
(161)
Microbial Sensitivity Tests
(159)
Medical Sciences
(138)
Pharmacology. Drug Treatments
(119)
Pharmacology & Pharmacy
(118)
Mycology
(109)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(105)
Drug Resistance, Fungal
(95)
Animals
(94)
Antifungal Agents - Therapeutic Use
(82)
Male
(82)
Immunology
(80)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment

Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective

Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

Fungal cell membrane—promising drug target for antifungal therapy

Clinical Impact of Polymerase Chain Reaction–Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study

Changing epidemiology of candidaemia in Australia

PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis

Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis

Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania

Exploring synergy between azole antifungal drugs and statins for Candida auris

Ibrexafungerp: A novel oral glucan synthase inhibitor

New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?

Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study

The effect of antifungal resistance development on the virulence of Candida species

New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany

Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus

COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance

Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa

Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India

Are Echinocandins Superior in Efficacy to Azoles?

Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands

Spectrophotometric azole and amphotericin B MIC readings against Aspergillus fumigatus sensu lato using the EUCAST 9.3.2 methodology. Are ≥90 and ≥95% fungal growth inhibition endpoints equally suitable?

Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim

Aktive Filter

Suchergebnisse filtern